PFLPhysiological Fitness Landscape

Biomarkers · Urine Biomarkers

Urinary Flow Rate

U-shaped: both low and high values carry risk. Not measured in our NHANES panel; the curve is synthesised from the published association.

Hazard ratio relative to the curve's reference value, as synthesised from the published association.

Published hazard ratio1.37top vs bottom quarter (95% CI 1.14–1.64) · Walkerton Health Study Cohort

Where people sit

Population percentiles (mL/min) by sex and age band. Cycle or source as recorded in the catalogue.

SexAge5th25thMedian75th95thnCycle / source
All20-390.300.661.101.823.852,4802017-2018
All40-590.280.621.031.703.602,4602017-2018
All60+0.260.580.981.623.452,5602017-2018
Allall0.280.621.041.723.657,5002017-2018
Menall0.290.641.061.753.753,6502017-2018
Womenall0.270.601.021.683.553,8502017-2018

What studies found when this marker was changed

Effects on the biomarker reported in the cited studies. They describe what happened in those populations, not a recommendation for anyone. See all catalogued interventions.

TypeInterventionReported effectEvidenceSource
clinicalAdequate oral and intravenous volume resuscitation in shockRestores urine flow > 0.5 mL/kg/hr, preventing acute kidney injuryrctRivers E, et al. N Engl J Med. 2001;345:1368-1377.
clinicalAcute tubular necrosis or complete urinary tract outflow obstructionOliguria (<0.3 mL/min) or absolute anuria (<50 mL/day)clinical guidelineBellomo R, et al. Crit Care. 2004;8:R204-R212.
clinicalSevere uncompensated hypovolemic or septic shock-80% to -100% collapse in urine outputclinical guidelineRhodes A, et al. Intensive Care Med. 2017;43:304-377.
dietHigh water intake (>2.5 L/day) in recurrent nephrolithiasis+50% to +100% flow increase, reducing kidney stone recurrence by 55%rctBorghi L, et al. J Urol. 1996;155:839-843.
pharmacologicSGLT2 inhibitors inducing mild osmotic natriuresis+300 to +500 mL/day increase in initial daily urine volumerctHeerspink HJ, et al. Circulation. 2016;134:752-772.